The Brazilian Health Regulatory Agency received a temporary authorization request for the Chinese immunizer Sinopharm. It has not undergone clinical trials in Brazil but has been tested in countries like the United Arab Emirates, Egypt, Argentina, and Peru.
LATEST NEWS
- Kuwait, Syria open markets to Brazilian products
- Brazil explores agricultural partnerships in Egypt
- Kuwait expands digital payments to 84%
- Algeria opens market to Brazil’s distillers grains
- Qatar opens applications for edtech accelerator
- Arab films seeking to compete for an Oscar
- E-commerce reaches USD 11.5 billion in UAE
- Brazil-Arab Gallery #72
